On March 8, 2023 Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of tumor-directed oncolytic immunotherapies, reported that members from the Replimune management team will present and host investor meetings at the following two conferences (Press release, Replimune, MAR 8, 2023, View Source [SID1234628318]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Barclays Global Healthcare Conference
Date: Wednesday, March 15, 2023
Fireside Chat Time: 2:05 pm EDT
Location: The Loews Miami Beach Hotel, Miami, FL
Jefferies Biotech on the Bay Summit
Date: Thursday, March 16, 2023
Location: 1 Hotel South Beach, Miami, FL
In-person 1×1 investor meetings only